Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -557.72x is 51% above its 1-year average of -1144.59x, near the high end of its 1-year range (-3941.69x–-225.50x).
51.27% above its 12-month average of -1144.59x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -641.93x.
INTEREST COVERAGE RATIO
-557.72x
INTEREST COVERAGE RATIO AVG TTM
-1144.59x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+51.27%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-8560.25%
vs the sector median at left
NOMAD Power Solutions, Inc.
Market Cap
$53.70M
Interest Coverage Ratio
-557.72x
TTM Avg
-1144.59x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$54.14M
Interest Coverage Ratio
-13.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.83M
Interest Coverage Ratio
-5.71x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$52.60M
Interest Coverage Ratio
-20.07x
TTM Avg
7.12x
3Y Avg
21.88x
5Y Avg
21.88x
Market Cap
$51.99M
Interest Coverage Ratio
-6.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$56.02M
Interest Coverage Ratio
-17.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $53.70M | -557.72x | -1144.59x | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -13.25x | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -5.71x | N/A | N/A | N/A |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -20.07x | 7.12x | 21.88x | 21.88x |
| Aldeyra The (ALDX)vs › | $55.25M | -18.51x | N/A | N/A | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | -6.14x | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $51.88M | N/A | N/A | N/A | N/A |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | -17.93x | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | N/A | N/A | N/A | N/A |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | N/A | N/A | N/A | N/A |
Interest Coverage
-557.7x
Debt/Equity
0.05
Current Ratio
12.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -641.93x |
| 2025-12-31 | -485.76x |
| 2025-09-30 | -3941.69x |
| 2025-06-30 | -428.07x |
| 2025-03-31 | -225.50x |
